Navigation Links
Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
Date:10/20/2009

PHILADELPHIA, Oct. 20 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Bernard Sweeney as Executive Director, Medical Devices. In this position, Mr. Sweeney will play a leading role in the operations, strategic planning, and corporate development of Premier Research's growing portfolio of medical device business. He will be based in Premier Research's Swiss office.

Mr. Sweeney has more than 20 years experience in medical device research and development, during which time he has supervised clinical trials leading to the market approval of more than 20 new products. He joins us from the British Standards Institute (BSi) where he had been the Director of Healthcare responsible for providing global regulatory approvals leading to market access for medical device companies across the world. Prior to his time at BSi, Mr. Sweeney held positions at both government agencies and medical devices manufacturers including Medilink East Midlands and Femcare Nikomed Group.

"Mr. Sweeney is an exceptional addition to our team," said Chris Nowell, Vice President, International Clinical Trial Management. "As we continue to expand our presence within the medical device market, Mr. Sweeney's substantial clinical and management expertise will be beneficial in continuing to establish Premier Research as the industry leader."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com

SOURCE Premier Research Group Limited


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Micronutrient Launches Supplement for Hearing Health
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Expands its Medical Device Operations to the United States
7. Premier Research Announces Milestone Investigational New Drug Application
8. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
9. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
10. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... ... vulnerable population in Syria’s civil war—babies and toddlers. , The situation in Syria ... are experiencing bombing, facing starvation, and dying from disease. The situation is intensifying ...
(Date:12/9/2016)... ... December 09, 2016 , ... Cellairis is a worldwide mobile device and ... iPhone , iPad and Samsung Galaxy devices with premium parts and accessories. ... to maximize convenience and accessibility for customers. While customers do their shopping, Cellairis can ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... 10th anniversary with the grand opening of the Sober College Robert Pfeifer Memorial ... two days, December 2-3, and was attended by an overwhelming amount of alumni, ...
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
Breaking Medicine News(10 mins):